The Test of Those Managing Pain With Their Own Pain

April 18, 2025 updated by: Ali Hüseyin Demir, Haseki Training and Research Hospital

The Test of Those Managing Pain With Their Own Pain" - A Questionnaire-Based Study on Pain Perception and Patient Empathy Among Physicians Actively Managing Pain

The study aims primarily to investigate physicians' awareness of their health status, empathy towards patients, and management processes through a questionnaire targeting physicians who diagnose and manage patients' pain.

Study Overview

Status

Not yet recruiting

Conditions

Intervention / Treatment

Study Type

Observational

Enrollment (Estimated)

175

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Contact

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

Yes

Sampling Method

Non-Probability Sample

Study Population

Physicians working in anesthesiology, algology, intensive care, neurology, and physical therapy.

Description

Inclusion Criteria:

  • Specialist physicians actively working in pain treatment and management (e.g., Algology, Physical Medicine and Rehabilitation, Anesthesiology, Neurology, Rheumatology, etc.) or physicians currently undergoing specialty training in these areas.
  • Physicians who volunteer to participate in the study and sign the informed consent form.
  • Physicians who have actively followed up patients and applied pain management techniques within the last year.

Exclusion Criteria:

  • Physicians who are not actively involved in pain management or who specialize in different medical fields.
  • Physicians who do not wish to complete the questionnaire or do not provide voluntary consent.
  • Physicians who complete the questionnaire incompletely or invalidly during the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
pain questionnaire
Time Frame: 1 week
questionnaire ( no pain:1 and worst pain:5 )
1 week

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Estimated)

April 11, 2025

Primary Completion (Estimated)

April 20, 2025

Study Completion (Estimated)

April 30, 2025

Study Registration Dates

First Submitted

April 10, 2025

First Submitted That Met QC Criteria

April 18, 2025

First Posted (Actual)

April 23, 2025

Study Record Updates

Last Update Posted (Actual)

April 23, 2025

Last Update Submitted That Met QC Criteria

April 18, 2025

Last Verified

April 1, 2025

More Information

Terms related to this study

Other Study ID Numbers

  • HASEKİ ANKET İLKE HOCA

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Subscribe